137 related articles for article (PubMed ID: 11328664)
61. Steady-state brain concentrations of antihistamines in rats: interplay of membrane permeability, P-glycoprotein efflux and plasma protein binding.
Mahar Doan KM; Wring SA; Shampine LJ; Jordan KH; Bishop JP; Kratz J; Yang E; Serabjit-Singh CJ; Adkison KK; Polli JW
Pharmacology; 2004 Oct; 72(2):92-8. PubMed ID: 15331914
[TBL] [Abstract][Full Text] [Related]
62. Carrier-mediated transport of H1-antagonist at the blood-brain barrier: mepyramine uptake into bovine brain capillary endothelial cells in primary monolayer cultures.
Yamazaki M; Terasaki T; Yoshioka K; Nagata O; Kato H; Ito Y; Tsuji A
Pharm Res; 1994 Jul; 11(7):975-8. PubMed ID: 7937557
[TBL] [Abstract][Full Text] [Related]
63. Differential cognitive effects of ebastine and (+)-chlorpheniramine in healthy subjects: correlation between cognitive impairment and plasma drug concentration.
Tagawa M; Kano M; Okamura N; Higuchi M; Matsuda M; Mizuki Y; Arai H; Fujii T; Komemushi S; Itoh M; Sasaki H; Watanabe T; Yanai K
Br J Clin Pharmacol; 2002 Mar; 53(3):296-304. PubMed ID: 11874393
[TBL] [Abstract][Full Text] [Related]
64. Diazepam effects on the performance of healthy subjects are not enhanced by treatment with the antihistamine ebastine.
Mattila MJ; Aranko K; Kuitunen T
Br J Clin Pharmacol; 1993 Mar; 35(3):272-7. PubMed ID: 8097102
[TBL] [Abstract][Full Text] [Related]
65. Comparative effects of nonsedating histamine H1 receptor antagonists, ebastine and terfenadine, on human Kv1.5 channels.
Valenzuela C; Delpón E; Franqueza L; Gay P; Vicente J; Tamargo J
Eur J Pharmacol; 1997 May; 326(2-3):257-63. PubMed ID: 9196279
[TBL] [Abstract][Full Text] [Related]
66. Functional relevance of carnitine transporter OCTN2 to brain distribution of L-carnitine and acetyl-L-carnitine across the blood-brain barrier.
Kido Y; Tamai I; Ohnari A; Sai Y; Kagami T; Nezu J; Nikaido H; Hashimoto N; Asano M; Tsuji A
J Neurochem; 2001 Dec; 79(5):959-69. PubMed ID: 11739607
[TBL] [Abstract][Full Text] [Related]
67. Ebastine during pregnancy and lactation in a patient with chronic urticaria: ebastine and carebastine levels in maternal serum, cord blood, breast milk and the infant's serum.
Saito J; Yakuwa N; Sandaiji N; Yagishita S; Kawasaki H; Suzuki T; Ozawa K; Kamura S; Yamatani A; Wada S; Sago H; Murashima A
J Eur Acad Dermatol Venereol; 2020 Sep; 34(9):e496-e497. PubMed ID: 32249465
[No Abstract] [Full Text] [Related]
68. P-glycoprotein as the drug efflux pump in primary cultured bovine brain capillary endothelial cells.
Tsuji A; Terasaki T; Takabatake Y; Tenda Y; Tamai I; Yamashima T; Moritani S; Tsuruo T; Yamashita J
Life Sci; 1992; 51(18):1427-37. PubMed ID: 1357522
[TBL] [Abstract][Full Text] [Related]
69. Inhibition of P-glycoprotein: rapid assessment of its implication in blood-brain barrier integrity and drug transport to the brain by an in vitro model of the blood-brain barrier.
Fenart L; Buée-Scherrer V; Descamps L; Duhem C; Poullain MG; Cecchelli R; Dehouck MP
Pharm Res; 1998 Jul; 15(7):993-1000. PubMed ID: 9688050
[TBL] [Abstract][Full Text] [Related]
70. Blood-brain barrier efflux transport.
Golden PL; Pollack GM
J Pharm Sci; 2003 Sep; 92(9):1739-53. PubMed ID: 12949994
[TBL] [Abstract][Full Text] [Related]
71. An evaluation of using rat-derived single-dose neuropharmacokinetic parameters to project accurately large animal unbound brain drug concentrations.
Doran AC; Osgood SM; Mancuso JY; Shaffer CL
Drug Metab Dispos; 2012 Nov; 40(11):2162-73. PubMed ID: 22899853
[TBL] [Abstract][Full Text] [Related]
72. Improvement of solubility and dissolution of ebastine by fabricating phosphatidylcholine/ bile salt bilosomes.
Islam N; Zahoor AF; Syed HK; Iqbal MS; Khan IU; Abbas G; Mushtaq M; Rehman MU; Rasul A; Ikram M; Ibrahim HM; Inam S; Irfan M
Pak J Pharm Sci; 2020 Sep; 33(5(Supplementary)):2301-2306. PubMed ID: 33832904
[TBL] [Abstract][Full Text] [Related]
73. Transport mechanism of an H1-antagonist at the blood-brain barrier: transport mechanism of mepyramine using the carotid injection technique.
Yamazaki M; Fukuoka H; Nagata O; Kato H; Ito Y; Terasaki T; Tsuji A
Biol Pharm Bull; 1994 May; 17(5):676-9. PubMed ID: 7920432
[TBL] [Abstract][Full Text] [Related]
74. Computer-assisted comparison of the structural and electronic dispositions of ebastine and terfenadine.
Segarra V; López M; Ryder H; Palacios JM; Roberts DJ
Drug Saf; 1999; 21 Suppl 1():45-61; discussion 81-7. PubMed ID: 10597868
[TBL] [Abstract][Full Text] [Related]
75. Affinity for the P-glycoprotein efflux pump at the blood-brain barrier may explain the lack of CNS side-effects of modern antihistamines.
Chishty M; Reichel A; Siva J; Abbott NJ; Begley DJ
J Drug Target; 2001 Jun; 9(3):223-8. PubMed ID: 11697207
[TBL] [Abstract][Full Text] [Related]
76. Efflux transport of tolbutamide across the blood-brain barrier.
Takanaga H; Murakami H; Koyabu N; Matsuo H; Naito M; Tsuruo T; Sawada Y
J Pharm Pharmacol; 1998 Sep; 50(9):1027-33. PubMed ID: 9811164
[TBL] [Abstract][Full Text] [Related]
77. Comparison of drug permeabilities across the blood-retinal barrier, blood-aqueous humor barrier, and blood-brain barrier.
Toda R; Kawazu K; Oyabu M; Miyazaki T; Kiuchi Y
J Pharm Sci; 2011 Sep; 100(9):3904-11. PubMed ID: 21638281
[TBL] [Abstract][Full Text] [Related]
78. Recent advances in the brain-to-blood efflux transport across the blood-brain barrier.
Hosoya K; Ohtsuki S; Terasaki T
Int J Pharm; 2002 Nov; 248(1-2):15-29. PubMed ID: 12429456
[TBL] [Abstract][Full Text] [Related]
79. Towards the optimal antihistamine: studies with ebastine.
Roberts DJ
Inflamm Res; 1998; 47 Suppl 1():S36-7. PubMed ID: 9561405
[No Abstract] [Full Text] [Related]
80. Penetration of intra-arterially administered vincristine in experimental brain tumor.
Boyle FM; Eller SL; Grossman SA
Neuro Oncol; 2004 Oct; 6(4):300-5. PubMed ID: 15494097
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
